SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (18504)2/2/1999 6:01:00 PM
From: VLAD  Read Replies (1) of 23519
 
martin,

It is my understanding that once the EU grants approval, the individual countries are supposed to grant licenses within 30 days.

So the big question is WHY OVER 60 DAYS LATER ALL THE EU COUNTRIES HAVE NOT GRANTED A LICENSE FOR MUSE SALES?

They sure didn't waste a heart beat getting Pfizer Viagra licensing almost IMMEDIATELY after the September 1998 EU approval.

Perhaps these European countries don't give a hoot about some small American biotech company's product and have more important licenses to grant amongst the large pharmaceutical companies. Another example of big business being given more favorable treatment. Money talks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News